@article{80b200e4f0614edab9df1661d67d59d9,
title = "Catecholaminergic Polymorphic Ventricular Tachycardia: A Review of Therapeutic Strategies",
keywords = "Catecholaminergic polymorphic ventricular tachycardia, Flecainide, RYR2-specific compounds, Sudden cardiac death, Therapeutic management, β-blockers",
author = "Bergeman, {Auke T.} and Wilde, {Arthur A. M.} and {van der Werf}, Christian",
note = "Funding Information: This study was supported by the ZonMW Priority Medicines for Rare Diseases and Orphan Drugs (grant 113304045 to Dr C. Van der Werf), eRare (E-rare 3–Joint Call 2015 to Dr A.A.M. Wilde), and the Netherlands CardioVascular Research Initiative: the Dutch Heart Foundation , Dutch Federation of University Medical Centres, Netherlands , the Netherlands Organisation for Health Research and Development and the Royal Netherlands Academy of Sciences (PREDICT2 to Dr A.A.M. Wilde).",
year = "2023",
month = sep,
day = "1",
doi = "https://doi.org/10.1016/j.ccep.2023.04.002",
language = "English",
volume = "15",
pages = "293--305",
journal = "Cardiac Electrophysiology Clinics",
issn = "1877-9182",
publisher = "W.B. Saunders Ltd",
number = "3",
}